QuickLink - Colorectal Cancer Trial Information
17,500 Participants Needed to Enroll in Major Colorectal Cancer Clinical
Trials
Breakthroughs in the Fight Against Colorectal Cancer
Recently a group of experts from the oncology research community, academia,
cancer cooperative groups, patient advocacy, and industry identified trials as
high priority colorectal clinical studies that address important research
opportunities and merit support for rapid completion. Combined, these ten large
studies require more than 17,500 participants.
The Coalition's Scientific Leadership Council in Genitourinary
(GI) Cancer presented these trials as part of their recommendations for the
future direction of colorectal cancer research at a forum in Washington DC in
December 2005 and at a major GI cancer meeting in San Francisco in January
2006.
Following is a list of these ten priority colorectal cancer clinical trials.
Click here to determine if you are eligible for these and other
treatment trials. Contact Kelly Glacken at 215-399-0424 or
kglacken@trialcheck.org if you have any questions.
Early-stage Colon Cancer (Combined With Surgery)
Early-stage Rectal Cancer (Combined With Surgery)
Protocol ID: E5204
Protocol Title: Phase III Study of Postoperative Oxaliplatin,
5-Fluorouracil and Leucovorin vs Oxaliplatin, 5-Fluorouracil, Leucovorin and
Bevacizumab for Patients With Stage II or III Rectal Cancer Receiving
Pre-operative Chemoradiation
View Trial Summary and Locations Where This Study Is Available
Advanced Colorectal Cancer (Colorectal Cancer That has Spread to Other
Organs)
Protocol ID: C80405
Protocol Title: A Phase III Trial of
Irinotecan/5-FU/Leucovorin or Oxaliplatin/5-FU/Leucovorin With Bevacizumab, or
Cetuximab (C225), or With the Combination of Bevacizumab and Cetuximab for
Patients With Untreated Metastatic Adenocarcinoma of the Colon or Rectum
View Trial Summary and Locations Where This Study Is Available
Protocol ID: NSABP-C-09
Protocol Title: Phase III Randomized Study of Adjuvant Therapy
Comprising Oxaliplatin and Capecitabine With Versus Without Hepatic Arterial
Infusion of Floxuridine in Patients Undergoing Surgical Resection and/or
Ablation for Hepatic Metastases From Colorectal Cancer
Accrual Completed
|